Literature DB >> 16472045

Inflammatory markers and type 2 diabetes.

John C Pickup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472045     DOI: 10.1089/dia.2006.8.1

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


× No keyword cloud information.
  6 in total

1.  Beta cell death in hyperglycaemic Psammomys obesus is not cytokine-mediated.

Authors:  A Jörns; K J Rath; O Bock; S Lenzen
Journal:  Diabetologia       Date:  2006-09-20       Impact factor: 10.122

Review 2.  Stress hyperglycemia and enhanced sensitivity to myocardial infarction.

Authors:  Keith A Webster
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

3.  Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake.

Authors:  Jan Bucerius; Venkatesh Mani; Colin Moncrieff; James H F Rudd; Josef Machac; Valentin Fuster; Michael E Farkouh; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2012-06-05       Impact factor: 24.094

4.  Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects.

Authors:  Stine Brinkløv Thomsen; Camilla Noelle Rathcke; Nils Bruun Jørgensen; Sten Madsbad; Henrik Vestergaard
Journal:  J Obes       Date:  2013-11-03

5.  Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease.

Authors:  A K Yadav; V Kumar; V Jha
Journal:  Indian J Nephrol       Date:  2016 Jul-Aug

6.  2. Inflammation, Cytokines and Chemokines in Chronic Kidney Disease.

Authors:  Christopher W K Lam
Journal:  EJIFCC       Date:  2009-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.